
Blis Technologies Limited — Investor Relations & Filings
Blis Technologies Limited specializes in the research, development, and commercialization of advanced probiotic strains specifically designed for oral health. The company focuses on the oral microbiome, utilizing patented strains of Streptococcus salivarius, most notably BLIS K12 and BLIS M18. These probiotics are engineered to support the natural immune defenses of the mouth and throat, providing protection against common bacterial infections and promoting healthy teeth and gums. The company's product portfolio includes formulations for throat health, immune support, and dental hygiene, targeting both consumer retail and ingredient supply markets. By leveraging proprietary fermentation and stabilization technologies, the company delivers clinically backed solutions that aim to maintain a healthy microbial balance in the oral cavity.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Strong revenue and underlying earnings growth | 2026-05-20 | English | |
| Strong YTD performance | 2026-02-18 | English | |
| Changes in BLIS Board | 2026-02-08 | English | |
| Strong revenue and underlying earnings growth | 2025-11-26 | English | |
| Probi agreement enhanced to strengthen alliance | 2025-10-27 | English | |
| Two New Patents Strengthen BLIS Global IP Position | 2025-09-19 | English |
Browse filings by year
11 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Entrada Therapeutics, Inc.
Clinical-stage biopharma developing EEV-based therapies for…
|
TRDA | US | Manufacturing |
|
Enwei Pharmaceutical Co., Ltd.
Produces Chinese patent medicines and chemical drugs for gy…
|
301331 | CN | Manufacturing |
|
ENZYCHEM LIFESCIENCES CORPORATION
Develops small molecule therapeutics for cancer, inflammati…
|
183490 | KR | Manufacturing |
|
Enzymatica AB
Develops medical devices for infections based on a propriet…
|
ENZY | SE | Manufacturing |
|
Epitomee Medical Ltd.
Develops ingestible therapeutic devices for chronic disease…
|
EPIT | IL | Manufacturing |
|
EPSILON HEALTHCARE LIMITED
Integrated medicinal cannabis company providing manufacturi…
|
EPN | AU | Manufacturing |
|
EQL Pharma AB
Develops and sells niche generic and specialty medicines, p…
|
EQL | SE | Manufacturing |
|
Erasca, Inc.
A clinical-stage oncology company developing therapies for …
|
ERAS | US | Manufacturing |
|
Eris Lifesciences Limited
Develops and markets branded generic pharmaceuticals for ch…
|
ERIS | IN | Manufacturing |
|
Ernexa Therapeutics Inc.
Biopharmaceutical company developing cell therapies for can…
|
ERNA | US | Manufacturing |
Blis Technologies Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/66168/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=66168 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=66168 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=66168 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 66168}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Blis Technologies Limited (id: 66168)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.